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Abstract
G-quadruplexes are higher-order DNA structures formed from guanine-rich sequences, and have been identified as
attractive anticancer drug targets. Elucidating the three-dimensional structure of G-quadruplex with 9-amino acridines and
the specific interactions involved in binding selectivity are the key to understanding their mechanism of action.
Fluorescence titration assays, competitive dialysis and NMR studies have been used to study the binding specificity of 9-
amino acridines to DNA. Structural models of the complexes with the telomeric DNA G-quadruplex based on NMR
measurements were developed and further examined by molecular dynamics simulations and free energy calculations.
Selective binding of 9-amino acridines for G-quadruplex sequences were observed. These compounds bind between A and
G-tetrads, involving significant p-p interactions and several strong hydrogen bonds. The specific interactions between
different moieties of the 9-amino acridines to the DNA were examined and shown to play a significant role in governing the
overall stabilities of DNA G-quadruplex complexes. Both 9-amino acridines, with similar binding affinities to the G-
quadruplex, were shown to induce different level of structural stabilization through intercalation. This unique property of
altering structural stability is likely a contributing factor for affecting telomerase function and, subsequently, the observed
differences in the anticancer activities between the two 9-amino acridines.
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Introduction
In the last years, tricyclic acridine-containing compounds have
been investigated as small molecule chemotherapeutic anticancer
agents [1,2]. Studies on the mechanism of action of acridine drugs
have shown these compounds are potent inhibitors of topoisom-
erase and telomerase function in replicating cells [3], which
ultimately leads to apoptosis and cell death.
Topoisomerase alters DNA topology through the decatenation
and relaxation of the supercoiled chromosomal DNA [4]. By
unwinding the double-stranded DNA, this essential enzyme
enables normal cellular DNA replication and transcription [4].
DNA topoisomerases exist in various eukaryotic and prokaryotic
forms [5] and are classified in two large groups, namely type I and
type II. Anti-cancer drugs targeting topoisomerase can also be
classified as either catalytic inhibitors or ‘‘topoisomerase poisons’’
depending on their mechanism of action [6]. The latter can be
further sub-classified into two groups: non-intercalating com-
pounds such as etoposide, and intercalators such amsacrine and
doxorubicin [7].
The telomere is a highly repetitive DNA region located at the
end of a linear chromosome. Its function is to protect the terminal
ends of chromosomes from being recognized as damaged DNA
and allows faithful chromosome replication during the cell cycle
[8,9]. Human telomeric DNA contains tandem repeats of the
sequence 59-TTAGGG-39. This guanine-rich strand can fold into
a four-strand G-quadruplex structure involving G-tetrads, which
are currently an attractive target for the development of anti-
cancer drugs [10,11,12].
A wide range of small molecules have been studied as G-
quadruplex-binding and stabilizing ligands [13]. Most of these
share common structural features, namely: (i) a planar heteroaro-
matic chromophore, which stacks by p-p interactions onto the G-
quartet motif at the terminus of a G-quadruplex; and (ii) short
alkyl chain substituents usually terminated by an amino group that
is fully cationic at physiological pH. The precise nature of these
substituents has been found to influence G-quadruplex affinity and
selectivity [12,14,15].
Guanine rich sequences are not only present in telomers [8,9]
but also in transcriptional regulatory regions of important genes
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implicated in cancer such as oncogenic promoters of human
vascular endothelial growth factor VEGF [16], c-myc [17], c-kit
[18], bcl-2 [19], N-ras [20], K-ras [21], and RET [22]. There are
strong evidences that the transcriptional control of these genes can
be modulated by G-quadruplex interacting agents [23,24]. For this
reason ligands that selectively bind and stabilize G-quadruplex
have become interesting anticancer drugs [25,26].
Ferguson and coworkers have recently described a series of 9-
aminoacridine compounds that inhibit topoisomerase II activity,
these compounds were initially synthesized as part of a library
screening study to identify anti-Herpes agents [27]. These
compounds have been shown to be active against a variety of
cancer cells in vitro and in vivo [14]. Mechanistic studies have
shown these compounds bind DNA and block the formation of
covalent DNA-Topo II complexes [28], stalling the cell cycle in
the G1-.S phase. This, in turn, induces apoptosis and
programmed cell death. Previous studies, however, have shown
that acridine compounds are also capable of binding telomeric G-
quadruplex structures with high affinity [29,30]. This is yet
another route by which compounds of this type may disrupt DNA
replication in rapidly dividing cancer cells. In this study, we
examine the binding affinity of several 9-amino acridines to
quadruplex DNA using competitive dialysis and spectroscopic
techniques. High field 2D-NMR experiments are also performed
to provide insight to the structural interactions that stabilize the
drug-DNA complex. Finally, the NOE data is applied to generate
structural models for evaluation using molecular mechanics and
dynamics techniques.
Results and Discussion
Competitive Dialysis and Fluorescence Titration
In order to evaluate the selectivity of the compounds for DNA
structures or sequences, a competitive dialysis experiment was
performed using 11 oligonucleotides (Table 1) representing several
nucleic acid structures [31,32,33]. We used T20 and the C-rich
complementary strand of bcl-2 as model compounds for single
stranded DNA sequences. As duplexes we used the self-comple-
mentary sequences Dickerson-Drew dodecamer and a 26 mer (ds26).
A parallel and an antiparallel triplex were also selected. Finally
several DNA sequences known to form G-quadruplex were
selected: TG4T [34] is a tetramolecular parallel G-quadruplex,
the TBA [35] is the antiparallel thrombin-binding aptamer, the
HT24 [36] is the human telomerase sequence, the cmyc and bcl-2
[19] are promoter sequences of c-myc and bcl-2 protooncogenes.
Competitive dialysis experiments show clear differences on the
affinity of ligands to a different DNA structures (Figure 1 and
Figure 2). Higher affinities are found in G-quadruplex sequences
present on the promoter regions of c-myc and bcl-2 oncogenes and
the human telomere sequence. Ligand 2 has a clear selectivity for
G-quadruplex-forming DNA sequences while compound 1 has
also an affinity for duplex ds26 as show in Figure 2.
Finally, the stability of the interaction complex formed by ligand
1 and 2 with G-quadruplex Htel and duplex ds6 was quantified by
recording the fluorescence spectra of a solution of the ligand after
the addition of increasing amounts of oligonucleotide. Changes in
the fluorescence spectra upon the addition of G-quadruplex were
observed in 1 and 2 (Figure S1). No significant changes in the
fluorescence spectra were observed upon the addition of duplex.
The increase of the fluorescence emission of these compounds
reflects their interaction with the G-quadruplex Htel.
Table S1 shows the logarithm of the binding constants
calculated using Equispec program assuming a 1:1 stoichiometry
DNA:ligand for the interaction complex. The calculated values are
around 105 M-1 which, according to literature, could be related to
intercalating species 37]. Groove-binding compounds are expected
to show larger association constants 38].
The high affinity of 9-amino acridines 1 and 2 for G-
quadruplex sequences and the strong interest in the bibliography
for G-quadruplex binders [25,26] prompted us to study in detail
the complex formed by the 9-aminoacridines and G-rich
sequences.
NMR 9-amino Acridines-DNA Experiments
NMR studies were performed to confirm and elucidate the
structure of the complexes formed between compounds 1 and 2
and DNA. The oligomers ds6, ds8, ds24, ds26 and Htel (Table 1)
were used as models for double stranded DNA and G-quadruplex
parallel structures respectively. 31P and 1H resonance experiments
were performed to derive both the mode of binding and the details
of the molecular model. Assignment of the phosphorous, of the
exchangeable and non-exchangeable protons for all oligonucleo-
tides was carried out on the basis of previously reported
assignments [39,40].
The sequential assignments in free and bound oligonucleotides
were performed by applying well established procedures for the
analysis of double stranded and G-quadruplex structures. 1H
assignments for 1 and 2 in absence of DNA were performed by
using ROESY, NOESY, TOCSY and COSY experiments.
Complete assignments are reported in Table 2 and 3.
NMR 9-amino Acridines and G-quadruplex Experiments
Titration experiments performed with 1 and 2 on the solution of
Htel show that the proton resonances of the drug become broad
and move up-field with respect to the free drug, just after the
addition of a small quantity, i.e. with R = [drug]/[DNA] = 0.25.
Increasing the R value from 0.25 to 3, the shielding of the drug
protons carries on and it spread over the whole drug molecule. In
order to better identify the drug protons in the complex, the
inverse titration experiment was performed, by adding increasing
amounts of DNA, from R = 20 to 2.0, to a solution of 1 at constant
concentration (0.2 mM). Figure 3 depicts the chemical shift
variation observed for protons of 1 during the titration experi-
ment. The chemical shift at higher R values must be related to the
free drug in solution, the addition of the oligonucleotide induces a
shielding of the drug protons. When an excess of oligonucleotide is
reached (low values of R), the drug is found predominantly in a
bound state. Actually, the chemical shift variation of a ligand is
due to the sum of different processes, involving both specific and
non-specific interactions with DNA (intercalation or groove
binding and outside binding) and drug self-aggregation phenom-
ena (Table 2).
On the other hand, our experience suggests that shift variations
of oligonucleotide proton signals arise when a ligand intercalates
between the base-pairs or binds to the minor groove [40,41,42].
The addition of the compound 1 to oligonucleotide solution
induced progressively changes in the chemical shift of the DNA
but only selected resonances are changed: i.e. NH imino and the
aromatic proton of G4 (Dd= 20.12 ppm and 20.11 ppm
respectively), H19 and H39 of T2 (Dd= 20.22 ppm and
20.19 ppm respectively). Moreover methyl of T1
(Dd= +0.13 ppm), H39 of T1 (Dd= +0.17 ppm) experience a
down field shift as well as aromatic protons of A3 and T2
(Dd= +0.1 ppm). The other protons are almost unchanged and a
very small up-field shift (Dd #0.1 ppm) was observed. In addition
the oligonucleotide protons, specially, H8 of A3 became broad due
to the complex formation (Figure 4). No separate signals were
observed for the free and bound species, because an intermediate
G-Quadruplex Interactions with 9-Amino Acridines
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exchange, with respect to the NMR time scale, of the drug with
the possible sites of binding of the oligonucleotide (Table 3).
The same experiments were performed with 2 (Figure 5). The
results are the same even if, due to the extensive overlapping of 2
and oligonucleotide protons, the analysis was quite difficult. All the
aromatic protons of ligand collapsed at 8.46 ppm, 7.88 ppm,
7.80 ppm and 7.38 ppm. Even in these case the addition of 2 to
the oligonucleotide solution causes notable chemical shift variation
on drug resonances, whereas the protons of TTAGGG are almost
unchanged a part from an up-field shift of NH imino G4 and the
aromatic proton of G4 (Dd= 20.10 ppm), a down-filed shift of
aromatic protons of T1, T2 and A3 (Dd= +0.14 ppm,
+0.11 ppm+0.12 ppm respectively), methyl of T1 and T2
(Dd= +0.2 ppm and 0.12 ppm, respectively) (Table 3).
All these findings give a first indication of a potential
intercalation binding mode of 1 and 2 near the T2A3G4 residues
adjacent to the G-quadruplex quartets.
The 1H NOE experiments, allowing the detection of specific
interactions between protons of the ligand and protons of the
DNA, were performed in order to recognize possible preferred
interaction sites. NOESY spectra were acquired with R = [drug]/
[DNA] = 0.5 and 3.
The sequential NH imino cross peaks between G4, G5 and G6
are still observed in 2D NOESY of the complexes and it proves the
position of the compound 1 between A3 and G4 without
disrupting the G quartets. The presence of NOEs interactions,
characteristic of the presence of G tetrads, together with the
weakness of H8A3/H8G4, H8A3/H6T2, H8A3/H19A3, H8A3/
H299T2 and of H8A3/MeT2 (Figure 6(a) and (b)) (total
disappearance in the case of the complex of 1 with Htel) in
comparison with the oligonucleotide alone, confirms a slight
distortion at these level of the sequence.
A certain number of NOE interactions between 1 and the DNA
was extracted despite of some overlapping between the signals of
TTAGGG and the 1 (Table 4). Examples are reported in
Table 1. Oligonucleotides sequences used in this study.
DNA code 59-sequence-39
T20 TTT TTT TTT TTT TTT TTT TT
24bclc CCC GCC CCC TTC CTC CCG CGC CCG
6-mer CGA TGC
Dickerson CGC GAA TTC GCG
ds26 CAA TCGGAT CGA ATT CGA TCC GAT TG
GA triplex GAA AGA GAGGAG GCC TTT TTG GAG GAG AAG+CCT CCT CTC TTT C
TC triplex CCT CCT CTC TTT CCC TTT TTC TTT CTC TCC TCC+GAA AGA GAG GAG G
TG4T TGG GGT
TBA GGT TGG TGT GGT TGG
HT24 TAG GGT TAG GGT TAG GGT TAGGGT
Htel TTA GGG
HtelT TTA GGG T
24bcl CGG GCG CGG GAGGAA GGG GGC GGG
cmyc GGG GAG GGT GGG GAG GGT GGG GAA GGT GGG G
ds6 CGA TCG
ds8 GCG ATC GC
ds24 AAG AAT TCT TAA GAA TTC TTA ATT
doi:10.1371/journal.pone.0057701.t001
Figure 1. Structure of 1 and 2.
doi:10.1371/journal.pone.0057701.g001
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Figure 6(a). The NOEs observed between the drug and the
oligonucleotide protons provide information regarding the se-
quence of the binding sites and confirm that 1 prefers the A3G4
step of TTAGGG G-quadruplex as intercalation site with the
indole positioned at A3T2 step. Specific intermolecular contacts
were found, involving aromatic protons of indole moiety with the
ribose protons of A3 and methyl of T2. For the acridine moiety,
we detected NOE contacts with aromatic protons and H39 of G4
and A3 residues. Following these few experimental NOEs, a model
of the complex was built.
In the case of Htel and 2 complex it was very hard to
unambiguously identify intermolecular interactions between 2 and
DNA, due to the extensive overlapping, but a low number of NOE
interactions was extracted from the 2D-NOESY and allowed to
identify the 2 position inside the G-quadruplex structure. An
aromatic proton (7.88 ppm) is close to the methyl, H29 and H39 of
T2 unit and another aromatic protons (8.46 ppm) is close to H19
and H29A3 and G4. As for 1, the interaction site for 2 is at the
level of T2 A3 and G4 residues.
NMR 9-amino Acridines-duplex Experiments
The dialysis experiments gave evidence that only the 1 interacts
with the oligonucleotide double helix ds26. In order to better
Figure 2. Results obtained by the competitive dialysis assays. The amount of ligand bound to each DNA structure is shown as a bar graph.
doi:10.1371/journal.pone.0057701.g002
Table 2. 1H chemical shift assignments for 1 and 2 (d) and shift variation of 1 (Dd) in the presence of Htela.
1 d free d bound Htel Dd (dbound–dfree) 2b d free
4A 8.36 8.10 20.26 1B 8.31
1B 8.28 8.10 20.18 3A 8.22
3B 7.92 7.74 20.18 4B 7.92
4B 7.87 7.74 20.13 1A 7.90
2A 7.80 7.66 20.14 2B 7.80
2B 7.55 7.48 20.07 3B 7.49
3A 7.55 7.20 20.35 2A 7.30
H1 7.27 7.00 20.27 H Phe 7.26–7.40
H4 7.25 7.00 20.25 CH2 ring1 4.00, 3.75, 3.49, 2.60, 2.45
H2 7.10 6.61 20.49 CH2 ring2 2.85, 2.15, 2.05, 1.86
H3 6.76 6.42 20.34 CH2 benz 3.55
Hind 6.94 6.60 20.34 CH 2.62
NH ind 9.75 9.60 20.15 NCH3 2.27
CH2-NHind 3.45 n.d. 2 2 2
CH2-NH 4.60 n.d. 2 2 2
NCH3 2.20 n.d. 2 2 2
CH2 ring 2.8,2.9
3.4,3.9
2.27 2.82, 4.10 20.53, 20.63 20.58,
0.20
2 2
aMeasured in ppm at 25uC, R = [drug]/[DNA] = 3;
bTentatively the chemical shift variations are within 20.08 ppm and 20.5 ppm.
doi:10.1371/journal.pone.0057701.t002
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understand the specific interaction involved, we performed
different NMR titration experiments. A short oligonucleotide, such
as ds6, was used in previous studies with intercalating agents
[40,43,44].
1H and 31P NMR titration experiments performed with 1 were
fruitless: the addition of 1 to the double helix did not induce any
chemical shield variation and did not induce line broadening of
the oligonucleotide resonances similar to those observed with
‘‘classical’’ intercalating agents (Figure S2–S3) [40,43,44,45].
These findings do not support the intercalation of 1 into the
double helix.
The self-complementary oligomers ds8 and ds24 were used as
models for CG- and AT-rich sequences respectively. These
sequences are longer than the previous one and are partially
contained into the ds26 sequence. In both cases NOESY
experiments performed on the compound 1 and duplex did not
show intermolecular interactions. Interestingly, the addition of 1 to
a solution of the double helix fragments induces a line broadening
of the resonances (Figure S4 and S5) of the oligomers. In particular
the imino protons, that present almost unchanged chemical shift
(Dd ,0.1 ppm) were observed to become very broad. The inverse
titration experiment was performed with ds24 and with ds26
oligonucleotides (Figure S6 and S7, Table S2), by adding
increasing amounts of DNA to a solution of 1 at constant
concentration. No relevant chemical shift variations were detected,
but a selective line broadening occurs for NH indole, aromatic 4A
and 2A protons of 1 with ds26. These findings suggest a specific
outside binding of 1 that can not happen with a shorter
oligonucleotide as ds6 because of the hindrance of the side chains.
Stability of 9-amino Acridines-Htel Complexes
The imino proton region of the NMR spectra of both complexes
clearly indicates the presence of G-quadruplex structure. Three
imino signals are observed between 10.0 and 11.5 ppm (Figure 7
(a), (b), (c)). These spectra are consistent with a single G-
quadruplex parallel structure similar to that of the Htel. In the
case of Htel/2 complex the exceeding number of imino signals in
the NMR spectra of at 5uC suggests the presence of several species
in equilibrium in slow exchange with respect to NMR time scale,
although the chemical shifts variation were not significantly altered
to consider a substantial change in topology.
Table 3. 1H chemical shift assignments for Htel (d) in the
presence of 1 and 2a.
TTAGGG/1 NH
H2/H8/
H6 H19 H29,H299 H39 H49 CH3
T1 2 7.43 6.05 2.42, 2.11 4.86 4.11 1.86
T2 2 7.43 6.05 2.42, 2.18 4.86 4.24 1.86
A3 2 8.10,
8.51
6.38 2.98, 2.98 5.19 4.57 2
G4 11.23 7.72 6.07 2.93, 2.60 5.04 4.32 2
G5 10.89 7.48 6.07 2.91, 2.68 5.03 4.39 2
G6 10.53 7.37 6.12 2.87, 2.66 4.88 4.53 2
TTAGGG/2 NH H2/H8/
H6
H19 H29,H299 H39 H49 CH3
T1 2 7.60 6.06 2.48,2.28 4.85 3.96 1.93
T2 2 7.46 6.23 2.49, 2.25 4.93 4.28 1.93
A3 2 8.10,
8.54
6.42 3.02, 3.02 5.22 4.61 2
G4 11.35 7.88 6.11 3.02, 2.76 5.03 4.43 2
G5 10.96 7.59 6.20 3.02,2.83 5.17 4.46 2
G6 10.61 7.46 6.23 3.00, 2.77 4.96 4.62 2
aMeasured in ppm at 25uC, R = [drug]/[DNA] = 3.0.
doi:10.1371/journal.pone.0057701.t003
Figure 3. 1H NMR spectra showing NH of indole moiety and aromatic protons of 1 in the free state (R = Htel/[1] = 0) and at different
R. High and low R values must be related to the free and bound state of 1 in solution respectively.
doi:10.1371/journal.pone.0057701.g003
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We performed melting experiments in order to see whether 1
and 2 stabilize or not the G-quadruplex structure. The imino
protons signals are diagnostic for the G-quadruplex formation and
the melting of the structure causes their disappearance due to the
break of the G quartet hydrogen bonds. The NH signals of Htel
without drugs disappeared between 45uC and 55uC (Figure 7(a))
whereas in the presence of 1 and 2 they can still be observed at
55uC and disappear up to 55uC (Figure 7 (b,c)). These findings
clearly indicate a significant stabilization of the G-quadruplex
structure by the interaction with ligands. The slight higher
stabilization induced by 2 compared with 1 are in agreement
with more favorable specific interactions between different
moieties of the ligand 2 to the DNA obtained by per residue
energy free studies and discussed below.
Model Generation
9-amino acridines-HtelT G-quadruplex complexes. The
59-TTAGGGT-39 sequence, HtelT, was used as model for
telomeric parallel G-quadruplex for the molecular docking of the
ligands. In both cases, Autodock placed the ligand in an
intercalated binding mode within the G-quadruplex. Docking
experiments show that 1 fit in the original gap region, located
between the virtual planes made by the four A and G bases, with
the tryptophan group adjacent to A10 and T16, and the acridine
moiety placed just under the A10 base, to give a p-p stacking
interaction. It should be noted that the best docked orientation
obtained for 1 has proven to be in agreement with experimental
data of the inter-molecular NOE interactions previously discussed
(as shown by the values of the distances reported in Table 4), thus,
supporting the proposed binding model. On the contrary,
compound 2 was unable to intercalate so efficiently, thus giving
rise to a less stable orientation. The differences observed with
respect to 1 could be due to the shift of the acridine moiety away
from the center of the G-quadruplex, probably because of the
greater steric hindrance produced by the presence of the
piperidine group.
The above described systems were further optimized using the
quantum mechanics/molecular mechanics (QM/MM) mixed
approach. This technique allowed us to obtain a better and more
complete description of the interactions with the G-quadruplex, as
well as an estimate of the structural changes induced in the G-
quadruplex by the binding of both ligands, 1 and 2. In both cases,
major differences were observed at the level of the acridine
Figure 4. 1H NMR spectra (11.5–10.2 ppm and 9.0–7.0 ppm) showing resonance of imino protons G4, G5 and G6 as well as the
aromatic protons at different R = [2]/Htel.
doi:10.1371/journal.pone.0057701.g004
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substituents, while the acridine ring maintained its position inside
the G-quadruplex, together with the p-p interactions previously
described (Figure 8 A and B). As we discuss below, molecular
dynamic simulations support the proposed models based primarily
on the observed NMR NOE’s and no other potential species were
observed during the simulation.
The position of compound 1 is stabilized by four strong
hydrogen bonds: two between the 9-amino acridine hydrogen and
N1A10 and N3A10 of 1.8 and 2.6 Å, other between the methyl
piperazine hydrogen and OPA10 of 1.95 Å and other between the
carbonyl oxygen and HN2G25 of 2.12 Å (Figure 9 A). Consid-
ering the structure of the G-quadruplex, the presence of 1 has
influenced mainly the A10 position. Indeed due to the presence of
the ligand, A10 undergoes a small clockwise rotation (about 6u)
with respect to the original structure. This rotation of A10 leads to
the formation of an additional hydrogen bond with T9, while
keeping the two original hydrogen bonds with A24 and A17.
In the case of 2 an orientation close to that of 1 was obtained.
This position is stabilized by six hydrogen bonds: three between
the 9-amino acridine hydrogen and N1A10, N2G11 and N7A17
of 3.1, 2.3 and 2.8 Å; other between the methyl piperazine
hydrogen and OPA10 3.3 Å; other between the carbonyl oxygen
and HN2G25 of 3.3 Å and other between the acridine nitrogen
and HN6A10 of 3.5 Å (Figure 9 C and D).
However, the biggest difference between 1 and 2 was found to
be at the level of their interaction with the G-quadruplex.
Differently from 1, the interaction of 2 resulted in a clockwise
rotation of G11 (about 9u) with respect to the original structure.
This rotation allowed G11 to form two new hydrogen bonds with
G26, while losing two of the four hydrogen bonds with G18 and
G25.
MD Simulation
Computational methods are widely used to investigate biomol-
ecules and complexes, and have been shown to provide valuable
deeper understanding of the structural, dynamic and energetic
properties [46,47,48].
Figure 5. 1H NMR spectra (11.5–10.2 ppm and 9.0–7.0 ppm), acquired at T = 256C in H2O, containing 25 mM KH2PO4, KCl 150 mM
and EDTA 1 mM (pH 6.7), showing resonance of imino protons G4, G5 and G6 as well as the aromatic protons at different R = [1]/
Htel.
doi:10.1371/journal.pone.0057701.g005
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To assess the overall structural stability of the 9-amino acridines
– G-quadraplex complex, we evaluated the root mean square
deviation (rmsd) of the whole structure over the course of the MD
simulation. G-quadruplex structures without potassium between
the G-tetrads were structurally less stable than K+ saturation
complexes and significant disorder was observed during the MD
simulation (results not shown). The rmsd values of the whole
complex remain ,4 Å (Figure S8) reflecting the fluctuations of the
terminal T residues, as they are not held tightly by hydrogen bonds
and, hence, are free to move during simulation. To consistently
examine the stability of the complex without the interference of
the terminal residues, the rmsd values for the A and G-quartets
core, with bound ligand 1 and 2, were examined and their
structural integrity were conserved in both cases with less than
2.5 Å rmsd (Figure 10). To examine how 9-amino acridines
occupies within the A and G tetrad, we evaluated the rmsd values
for the ligands 1 and 2 within the G-quadruplex, showing that
acridine scaffolds are free to move within the gap region between
the virtual planes made by the four A and G bases, but remains
within the G-quadruplex (Figure 10).
To examine the overall stability of the structural complex, MD
simulations at elevated temperature were also performed. The goal
was to identify the specific interactions observed in our NMR
studies that can play an important role in maintaining the G-
quadruplex structure. We expect transient interactions will be
subsided at elevated temperature allowing us to identify the stable
contacts essential for retaining the overall G-quadruplex structure.
The rmsd values for these studies are shown in Figure S9–S10.
The MD simulation at 400 K indicates that the rmsd values for
the A and G-quartets core with bound ligand 2 is similar to value
obtained at 298 K. In the case of ligand 1, the higher value of
rmsd indicates that interactions established between ligand and
HtelT were not maintained at high temperature (Figure S9).
Significant disorder was observed during the simulation at 500 K,
only G-quadruplex with bound ligand 2 keep the G-quadruplex
structure as indicated the rmsd value for the A and G-quartets core
(Figure S10). This suggests that ligand 2 has a more stabilizing
effect on the quadruplex structure as compared to 1.
Figure 6. Selected region of 2D NOESY spectra of Htel/1 (a) and Htel/2 (b) complexes at 256C in H2O, containing 25 mM KH2PO4,
KCl 150 mM and EDTA 1 mM (pH 6.7). The weakness of H8A3/H2’’T2 and of H8A3/MeT2 (total disappearance in the case of Htel/1) confirms a
slight distortion at these level of the sequence. The peaks A, B and C are intermolecular NOEs, (A) H1 or H4 with CH3T2, (B) H1 or H4 with H29, H299 A3,
(C) H3 with H29,H299A3, (D) Ar with MeT2 (E) Ar with H29,H299 T2 (F) Ar with H29,H299 A3.
doi:10.1371/journal.pone.0057701.g006
Table 4. Inter-molecular NOE interactions between protons
of the 1 with protons of Htela.
TTAGGG 1 Theoretical distances(Å)
CH3 T2 H1 or H4 4.31 (H4)
H29 A3 H1 or H4 4.37 (H4)
H29 A3 H2 or H3 4.33 (H3)
H19 A3 H2 or H3 1.68 (H3)
H39, G4 or A3 H3A 3.96 (A3)
The distances are calculated on the basis of the 1 best docked conformation.
aAcquired at 25uC, R = [drug]/[DNA] = 3. 29 H and 20 H stand for low field and up
field proton respectively.
doi:10.1371/journal.pone.0057701.t004
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We also examined the essential hydrogen bonding for 9-amino
acridines binding. An interaction was considered to be a hydrogen
bond if the distance between the hydrogen donor and acceptor
was less than 3.5 Å. As mentioned above four hydrogen bounds
are formed with ligand 1, only the bond between the methyl
piperazine hydrogen and OPA10 was not kept during the dynamic
simulation due to the rotation of the N-Me-Piperazine ring.
Moreover, during the simulation the rotation of the indole group
has allowed the formation of two additional hydrogen bonds
between NH and OA17 and OPA17 from 6.4 and 5.0 A to 2.7
and 1.9 Å (Figure 9B). In the case of ligand 2, six hydrogen
bounds are observed, but weaker compared with hydrogen bonds
formed with ligand 1. The hydrogen bond between 9-amino
acridine hydrogen and N2G11 and N7A17 and between N-Me
piperazine hydrogen and OPA10 were kept during the simulation
(Figure 9C and D).The N-Bz-piperidine group acts as the indole in
1 but, probably due to the bulkiness of the phenyl group, in this
case the quaternary nitrogen fails to approach the phosphate
group of A17 enough to form hydrogen bonds.
Finally, the interaction energy per residue between compound 1
and 2 to individual nucleotide residues of HtelT G-quadruplex are
shown in Figure 11. Examination of the interactions revealed a
slight variation in the signature of binding between compounds 1
and 2 with the G-quadruplex DNA (Figure 11A). The main
difference is found in the G25. Figure 10 B-C show the interaction
energy per residue between moieties that form compound 1 and 2.
While as piperazine moiety in compound 2 has an energetic
favorable contribution, in compound 1 this interaction is not
favorable. The slight higher HtelT stabilization induced by
compound 2 observed during NMR melting experiments may
be due to the most favorable interactions between the different
moieties of 2 with the G-quadruplex.
Conclusions
In summary we have used fluorescence titration assays,
competitive dialysis, NMR studies and molecular dynamics
simulations in order to determine the binding properties of
preclinical 9-amino acridines to DNA. A selectivity of acridine
derivatives for G-quadruplex structures was observed. Slightly
higher stabilization of the structural complex induced by the
interaction of compound 2 as compared to 1 was observed by
NMR melting experiments. Detailed structural studies by NMR
and molecular dynamic simulation on G-quadruplex telomeric
complex showed the core of both 9-amino acridines intercalates
directly between the virtual planes made by the four A and G
Figure 7. Imino protons regions of the NMR spectra of Htel (a) Htel/1(b) and Htel/2 (c) at different temperatures.
doi:10.1371/journal.pone.0057701.g007
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bases via p- p interactions, but do not exactly overlap. The indole
moiety in ligand 1 does not fit as closely to the G-quadruplex
groove as the N-Bz-piperidine group in ligand 2. Structurally,
ligand 1 establishes only four strong hydrogen bonds with
telomeric G-quadruplex while ligand 2 established six. The most
significant interaction observed involved the carbonyl oxygen with
G25 for both ligands and the 9-amino acridine hydrogen with A10
for ligand 1 and with A17 and G11 for ligand 2. Per residue
interaction free energy profiles of each compounds showed the
substituents of ligand 1 exhibit two distinctly unfavorable
interactions between the piperazine group to G25 and the
piperidine group to A10 (Figure 11B). The strength of these
interactions was further examined by MD simulations at elevated
temperatures showing the interactions between ligand 2 and the
G-quadruplex are tighter than that of ligand 1. Rmsd analysis over
the course of simulation further support the slight enhanced
structural stabilization by compound 2 over compound 1 with
relative lower rmsd among the unbound and bound complexes.
The slightly stronger interactions between ligand 2 to the G-
quadruplex over ligand 1 could explain the experimental
differences in structural stabilities between the two 9-amino
acridines. The ability of 9-amino acridines to exhibit similar
binding affinity to the G-quadruplex while inducing different level
of structural stabilization through intercalation could be a unique
strategy for altering the overall biological function of telomerase
and their subsequent anticancer activity. These findings will assist
in the understanding the parameters influencing the G-quadruplex
– ligand interaction and will serve as an enhanced platform for
rational drug design.
Materials and Methods
Compounds and Oligonucleotide Synthesis
Compounds 1 and 2 were synthesized according to published
procedures [27]. All the standard phosphoroamidites and reagents
for DNA synthesis were purchased from Applied Biosystems and
from Link Technologies. The synthesis of the oligonucleotides was
performed at 1 mmol scale on an Applied Biosystems’ DNA/RNA
3400 synthesizer by solid-phase 2-cyanoethylphosphoroamidite
chemistry. The studied sequences are listed in table 1. The
resulting oligonucleotides were purified by HPLC and desalted in
a Sephadex (NAP-10) G25 column.
Competitive Dialysis Studies
A 100 ml of a 50 mM oligonucleotide in potassium phosphate
buffer was introduced into a separated dialysis unit and a blank
sample containing only buffer. All dialysis units were allowed to
equilibrate during 24 h at room temperature in a beaker
containing the 1 mM solution of the appropriate acridine
derivative. At the end of the dialysis experiment, the amount of
ligand bound to the DNA was quantified by fluorescence after the
digestion of the oligonucleotide (lex and lem were set to 265 nm
and 435 nm, respectively) [49].
NMR Spectroscopy
The NMR spectra were recorded by Bruker AV-600 spectrom-
eter operating at a frequency of 600.10 MHz for 1H and
242.94 MHz for 31P nuclei, equipped with a z-gradient triple
resonance TXI and 5 mm BB probe. 1H and 31P spectra (broad-
band 1H decoupled mode) were recorded at variable temperature
ranging from 5uC to 75uC. Chemical shifts (d) were measured in
Figure 8. Lateral (A) and upper (B) views of the best docked conformations for 1 and 2. 1 is shown in green stick and 2 in yellow stick. In
DNA, the base pairs are shown using the ladder representation, with the backbones displayed as arrows.
doi:10.1371/journal.pone.0057701.g008
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ppm. 1H and 31P NMR spectra were referenced respectively to
external DSS (2,2-dimethyl-2-silapentane-5-sulfonate sodium salt)
set at 0.00 ppm and MDA (methylenedisphosphonic acid) set at
16.8 ppm. Estimated accuracy for protons is within 0.01 ppm, for
phosphorous is within 0.03 ppm.
Standard homonuclear 2D-NMR experiments were performed
to assign the resonances of the complexes, including DQF-COSY,
TOCSY and NOESY [50,51]. The mixing times were set at
150 ms and 300 ms for NOESY and 60 ms for TOCSY. For
samples in H2O, the excitation sculpting sequences from standard
Bruker pulse program libraries were employed. Typically,
204861024 data points were acquired using TPPI and trans-
formed to a final 4 K64 K real data matrix after apodisation with
a 90u and 90u-shifted sine-bell squared function in f2- and f1-
domain, respectively. Baseline correction was achieved by a 5th-
degree polynomial function. 1H assignments for ligands were
performed by using ROESY (spin lock 300 ms) and TOCSY
experiments. The sequential assignments in free and bound
Figure 9. Time dependence of hydrogen bond distances observed between G-quadruplex and ligand 1 (A and B) and 2 (C and D).
A)1. Hb and N1A10 (cyan) 2. Hb and N3A10 (green) 3. Hf and OPA10 (blue) 4. OD and HN2G25 (red). B) 1. Hi and OaA17 (blue) 2. Hi and OPA17 (red). C)
1. Hb and N1A10 (blue) 2. Nc and HN6A10 (red) 3. Hf and OPA10 (green) D) 1. Hb and N2G11 (blue) 2. Hb and N7A17 (red) 3. Od and HN2G25 (green).
doi:10.1371/journal.pone.0057701.g009
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oligonucleotides were performed by applying well established
procedures for the analysis of double stranded and quadruplex
structures. The program Sparky [52] was used to assign the
NOESY cross-peaks. The G-quadruplex Htel and duplexes ds6,
ds7 and ds32 were previously assigned [39,40].
The samples for NMR measurements were dissolved in 500 ml
H2O/D2O (9:1) containing 25 mM KH2PO4, KCl 150 mM and
EDTA 1 mM (pH 6.7) for the G-quadruplex Htel and containing
10 mM KH2PO4, KCl 70 mM and EDTA 0.2 mM (pH 7.0) for
the double helix ds6, ds7, ds26 and ds24. The final concentration
of the oligonucleotides was ranging between 0.2–0.7 mM. A stock
solution of 1 and 2 was prepared in DMSO-d6 at the
concentration of 20 mM.
NMR titration was performed by adding increasing amounts of
1 and 2 to the oligonucleotides solution at R = [Ligand]/[DNA]
ratio equal to 0, 0.25, 0.5, 0.75, 1, 2 and 3 and in inverse order, by
adding increasing amounts of DNA to a solution of 1 from R = 40
to R = 1.0.
Fluorescence Assays
The study of the interaction equilibrium of 1 and 2 and the G-
quadruplex Htel or the duplex ds6 consists of recording the
fluorescence spectra of a 1 mM solution of the drug after the
addition of increasing amounts of oligonucleotide (from 0 to
25 mM) in potassium phosphate buffer (185 mM NaCl, 185 mM
KCl, 6 mM Na2HPO4, 2 mM NaH2PO4, 1 mM Na2 EDTA at
pH 7).
The emission spectra of the resulting solutions were recorded
from 300 to 500 nm at 265 nm excitation wavelength at 25C. The
macroscopic binding constant corresponding to complex forma-
tion was calculated from the multivariate analysis of fluorescence
data recorded in the range 300–425 nm using the hard modeling
program Equispec [53].
Molecular Modeling
The model was built based on a G-quadruplex NMR structure
59-TTAGGGT-39 HtelT, in complex with a quinacridine-based
ligand (N,N’-(dibenzo[b,j] [1,7]phenanthroline-2,10-diyldimetha-
nediyl)dipropan-1-amine) (PDB code 2JWQ) [46]. After the
separation of the coordinates of ligands and DNA, polar
hydrogens were added with the GROMACS package [54] using
the GROMOS 53a6 force field [55].The structures of 1 and 2
were refined using a systematic conformer, search followed by
geometry optimization of the lowest energy structure with
MOPAC (PM3 Methods, RMS gradient 0.0100) [56].
Molecular docking experiments were performed with Autodock
4.0, which uses an empirical scoring function based on the free
energy of binding [57,58]. The 9-aminoacridines (1 and 2) and the
DNA G-quadruplex were further processed using the Autodock
Tool Kit (ADT) [59]: Gasteiger-Marsili charges [60] were assigned
to 1 and 2 and Cornell parameters were used for the phosphorous
atoms in the DNA. Solvation parameters were added to the final
docked structure using Addsol utility. Structures with less than
1.0 Å root-mean-square deviation (rmsd) were clustered together
and representative model of each cluster was selected based on the
most favorable free energy of binding. Visual inspection was
carried out to select the final structure with the expected mode of
intercalation, minor groove binding, or others (major groove
binding, interaction with phosphate groups, etc.).
In the current study, we used the pseudo-bond ab-initio QM/
MM approach as implemented in Gaussian-03 [61]. For the QM/
MM calculations, the DNA-ligand system resulting from the
docking study was first partitioned into a QM subsystem and an
MM subsystem. The reaction system used a smaller QM
subsystem consisting of the ligand and bases within 3.5 Å, whereas
the rest of the system (the MM subsystem) was treated using the
AMBER force field, together with a low memory convergence
algorithm. The boundary problem between the QM and MM
subsystems was treated using the pseudo-bond approach. With this
G-quadruplex-substrate QM/MM system, an iterative optimiza-
tion procedure was applied to the QM/MM system, using
B3LYP/3-21G* QM/MM calculations, leading to an optimized
structure for the reactants. The convergence criterion used was set
to obtain an energy gradient of ,1024, using the twin-range cutoff
Figure 10. Time dependence of the RMSD of ligand 1 and 2 on the complex (cyan and yellow, respectively) and A and G-quartet
heavy atoms (blue) with ligand atoms (1 and 2 are shown in red and green, respectively) at 298 K.
doi:10.1371/journal.pone.0057701.g010
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method for nonbonded interactions, with a long-range cutoff of
14 Å and a short-range cutoff of 8 Å.
MD Simulation
All simulations were carried out using IMPACT (New York,
NY) with the OPLS2005 force field [62] and the TIP3P water
model [63] at 298, 400 and 500 K. Two potassium ions were
manually overlayed into the central channel between the G-
quartet planes in the complex models. Each DNA complex was
solvated in a rectangular box with a 10 Å water buffer from the
DNA. Na+ and Cl2 counterions were added at 5 Å from the box
boundary to neutralize the total charge of the system.
Each system was initialized by a 1000-step conjugate gradient
energy minimization. The simulations were carried out under the
periodic boundary condition using particle mesh Ewald [64]. The
SHAKE method [65] was employed to restrain all hydrogen
bonds. Atoms involved in NOE’s bonds were restrained to their
experimental value at (500 kcal/mol Å). Snapshots of the
simulated trajectories were collected at 1 ps time intervals.
Supporting Information
Figure S1 Fluorescence titration spectra. Fluorescence
spectra of a 1 mM solution of 1 (left) and 2 (right) after the addition
of increasing amounts of Htel (from 0 to 25 mM) in potassium
phosphate buffer. Excitation wavelength is 265 nm.
(TIF)
Figure S2 1H NMR spectra (15–12 ppm and 9.0–
5.5 ppm) showing resonance of imino and aromatic
and ribose H19 protons region at different R = [1]/[ds6].
(TIF)
Figure S3 1H decoupled 31P NMR spectra of (a) ds6 at
T = 256C, (b) R = [1]/[ds6] = 3.0.
(TIF)
Figure S4 1H NMR spectra (15–12 ppm and 10–
5.5 ppm) showing resonance of imino and aromatic
and ribose H19 protons region at different R = [1]/[ds8].
(TIF)
Figure S5 1H NMR spectra (15–12 ppm and 10–
5.5 ppm) showing resonance of imino and aromatic
and ribose H19 protons region at different R = [1]/
[ds24].
(TIF)
Figure S6 1H NMR spectra showing NH of indole
moiety and aromatic protons of 1 in the free state
(R = [ds24]/[1] = 0) and at different R. High and low R
values must be related to the free and bound state of DMF1 in
solution respectively.
(TIF)
Figure S7 1H NMR spectra showing NH of indole
moiety and aromatic protons of 1 in the free state
(R = [ds26]/[1] = 0) and at different R. High and low R
values must be related to the free and bound state of 1 in solution
respectively.
(TIF)
Figure S8 Time dependence of the RMSD of heavy
atoms of complete G-quadruplex (blue) with ligand
atoms (1 and 2 are shown in red and green, respectively)
at 298 K.
(TIF)
Figure S9 Time dependence of the RMSD of ligand 1
and 2 on the complex (cyan and yellow, respectively) and
A and G-quartet heavy atoms (blue) with ligand atoms (1
and 2 are shown in red and green, respectively) at 400 K.
(TIF)
Figure S10 Time dependence of the RMSD of ligand 1
and 2 on the complex (cyan and yellow, respectively) and
A and G-quartet heavy atoms (blue) with ligand atoms (1
and 2 are shown in red and green, respectively) at 500 K.
(TIF)
Table S1 Logarithm of the binding constants calculated
using Equispec program. n.d. not determinded due to
lack of changes in the fluorescence spectra.
(DOCX)
Table S2 Table S2. Selected 1H chemical shift assign-
ments for ds24 (d) in the presence of 1a.
(DOCX)
Figure 11. Per residue interaction energy in Kcal/mol between
compound 1 (blue) and 2 (red) (A), between acridine (blue),
piperazine (red) and tryptophan (green) moiety in compound 1
(B) and between acridine (blue), piperazine (red) and piperi-
dine (green) in compound 2 (C).
doi:10.1371/journal.pone.0057701.g011
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